ICD-10-CM Billable Code

Q81.0

Epidermolysis bullosa simplex

Clinical Classification Guidelines

Excludes Type 1

  • Cockayne's syndrome (Q87.19)

Medical Intelligence & Overview

Epidermolysis bullosa simplex (EBS) is a genetic skin disorder characterized by skin fragility. It causes the skin to blister and peel easily, often in response to minor injuries or friction. This condition usually appears in infancy or childhood and can vary in severity from mild to more pronounced symptoms. Despite its visible effects, EBS generally does not lead to life-threatening complications, but it requires careful skin management to prevent discomfort and secondary infections.

Causes & Symptoms

Clinical Causes: Genetic mutations affecting keratin genes that provide strength to skin cells Inheritance patterns include autosomal dominant transmission, meaning only one copy of the mutated gene can cause the condition Possible spontaneous mutations with no family history in rare cases

Key Symptoms: Formation of blisters on the skin, often on hands, feet, or other areas prone to friction Skin tearing or peeling easily at sites of minor trauma Periods of skin soreness or discomfort following blister formation Mild skin thinning and fragility in affected areas In some cases, nail abnormalities or thickening may be present

Diagnostic & Treatment

Diagnosis Path: Diagnosing epidermolysis bullosa simplex involves a combination of medical history, physical examination, and laboratory tests. Skin biopsies are often performed to observe the level of blister formation under a microscope, and genetic testing can identify specific mutations in keratin genes. Differentiating EBS from other types of epidermolysis bullosa is essential for appropriate management.

Treatment Protocols: Gentle skin handling to minimize trauma and blister formation Use of soft, non-abrasive clothing and bedding Application of protective dressings and creams to reduce friction Prompt treatment of blisters to prevent infection Adequate pain management during flare-ups Regular skin assessments by healthcare providers Monitoring for secondary infections and treating them promptly Nutritional support and physical therapy if needed for hand and foot mobility

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Q81.0 a billable ICD-10 code?
Yes, Q81.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Q81.0?
Clinical documentation must specify the nature of Epidermolysis bullosa simplex and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

epidermolysis bullosa simplex